Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Xeris Pharmaceuticals

NASDAQ XERS
$1.90 0.01 0.53%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

266.98M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
393.95M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.81
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
140.51M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-19.15 %

Upcoming events Xeris Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Xeris Pharmaceuticals

Stock analysis Xeris Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-4.15 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-39.37 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-12.33 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-3.97 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
701.69 9.54

Price change Xeris Pharmaceuticals per year

2.11$ 7.94$
Min Max

Summary analysis Xeris Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Xeris Pharmaceuticals

Revenue and net income Xeris Pharmaceuticals

All parameters

Stock news Xeris Pharmaceuticals

All news
23 August 2021 в 22:45

Xeris Pharmaceuticals Shares Rise 18% on FDA Approval for sNDA

23 August 2021 в 22:39

Xeris Pharmaceuticals Shares Rise 18% on FDA Approval for sNDA

23 August 2021 в 18:24

Xeris Pharmaceuticals Gets FDA Approval for sNDA for Diabetes Treatment

23 August 2021 в 18:24

Xeris Pharmaceuticals Gets FDA Approval for sNDA for Diabetes Treatment

About company Xeris Pharmaceuticals

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. It markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for primary periodic paralysis. The company also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was founded in 2005 and is headquartered in Chicago, Illinois.
Address:
180 North LaSalle Street, Chicago, IL, United States, 60601
Company name: Xeris Pharmaceuticals
Issuer ticker: XERS
ISIN: US98422E1038
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-06-21
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.xerispharma.com

On which stock exchange are Xeris Pharmaceuticals (XERS) stocks traded?

Xeris Pharmaceuticals (XERS) stocks are traded on NASDAQ.

What is the ticker of Xeris Pharmaceuticals stocks (XERS)?

The stock ticker of Xeris Pharmaceuticals’s stocks or in other words, the code is XERS. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Xeris Pharmaceuticals (XERS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Xeris Pharmaceuticals (XERS) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Xeris Pharmaceuticals (XERS) stocks traded?

Xeris Pharmaceuticals (XERS) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Xeris Pharmaceuticals (XERS) stocks today?

The current price of Xeris Pharmaceuticals stocks on 15.05.2024 is 1.9 dollars. per share.

What is the dynamics of Xeris Pharmaceuticals (XERS) stocks from the beginning of the year?

Xeris Pharmaceuticals (XERS) quotes have increased by -16.11% from the beginning of the year up to 1.9 dollars. per 1 stocks.

How much did Xeris Pharmaceuticals (XERS) stocks increase in мае 2024?

This month Xeris Pharmaceuticals (XERS) quotes have increased by 8.57% to 1.9 dollars. per share.

How much are Xeris Pharmaceuticals (XERS) stocks worth?

Today, on October, 15.05.2024 Xeris Pharmaceuticals’s (XERS) stocks cost 1.9 dollars..

What is the market capitalization of Xeris Pharmaceuticals (XERS)?

Capitalization is the market value of Xeris Pharmaceuticals (XERS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 15.05.2024, the market capitalization of Xeris Pharmaceuticals (XERS) is estimated at about 266976423 dollars.